Items related to Cancer Therapeutics: Experimental and Clinical Agents...
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development) - Softcover
Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of identifying molecules that have the potential to be therapeutically important in human malignant disease. "Screening" remains the most important and most controversial method in cancer drug discovery. In vitro screens have generally focused on cytotoxicity and have identified several highly cytotoxic molecules. Other endpoints available in vitro are inhibition of proliferation, 3 inhibition of [ H]thymidine incorporation into DNA and various viability assays, based most frequently on dye exclusion or metabolism.
"synopsis" may belong to another edition of this title.
Review:
"...extremely readable...excellent treatment of drugs such as naphthalimides...Each chapter is succinct and well-written." -Cancer Forum
"...a most important source of literature for all those who are involved in basic cancer research and in the clinical care of cancer patients in different fields of medicine." -Haematologia
"...a most important source of literature for all those who are involved in basic cancer research and in the clinical care of cancer patients in different fields of medicine." -Haematologia
"About this title" may belong to another edition of this title.
- PublisherHumana
- Publication date2010
- ISBN 10 1617370460
- ISBN 13 9781617370465
- BindingPaperback
- Number of pages463
- EditorTeicher Beverly A.
Buy New
Learn more about this copy
£ 188.60
Shipping:
£ 3.17
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Mar2811580148030
Buy New
£ 188.60
Convert currency
Stock Image
Cancer Therapeutics: Experimental and Clinical Agents
Published by
Humana Press
(2010)
ISBN 10: 1617370460
ISBN 13: 9781617370465
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9781617370465_lsuk
Buy New
£ 183.96
Convert currency
Seller Image
Cancer Therapeutics
Published by
Humana Press
(2010)
ISBN 10: 1617370460
ISBN 13: 9781617370465
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Seller Inventory # 4256617
Buy New
£ 159.38
Convert currency
Seller Image
Cancer Therapeutics
Published by
Humana Press Nov 2010
(2010)
ISBN 10: 1617370460
ISBN 13: 9781617370465
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of identifying molecules that have the potential to be therapeutically important in human malignant disease. 'Screening' remains the most important and most controversial method in cancer drug discovery. In vitro screens have generally focused on cytotoxicity and have identified several highly cytotoxic molecules. Other endpoints available in vitro are inhibition of proliferation, 3 inhibition of [ H]thymidine incorporation into DNA and various viability assays, based most frequently on dye exclusion or metabolism. 464 pp. Englisch. Seller Inventory # 9781617370465
Buy New
£ 189.40
Convert currency
Seller Image
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development) [Paperback ]
Published by
Humana Press
(2010)
ISBN 10: 1617370460
ISBN 13: 9781617370465
New
Soft Cover
Quantity: 10
Seller:
Rating
Book Description Soft Cover. Condition: new. Seller Inventory # 9781617370465
Buy New
£ 215.75
Convert currency
Seller Image
Cancer Therapeutics : Experimental and Clinical Agents
Published by
Humana Press
(2010)
ISBN 10: 1617370460
ISBN 13: 9781617370465
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cancer drug discovery has been and continues to be a process of ingenuity, serendip ity, and dogged determination. In an effort to develop and discover better therapies against cancer, investigators all over the world have increased our knowledge of cell biology, biochemistry, and molecular biology. The goal has been to define therapeuti cally exploitable differences between normal and malignant cells. The result has been an increased understanding of cellular and whole-organism biology and an increased respect for the flexibility and resiliency ofbiologically systems. Thus, as some new therapeutic targets have been defined and new therapeutic strategies have been attempted, so have some new biological hurdles resulting from tumor evasion of the intended therapeutic attack been discovered. Historically, anticancer drugs have originated from all available chemical sources. Synthetic molecules from the chemical industry, especially dyestuffs and warfare agents, and natural products from plants, microbes, and fungi have all been potential sources of pharmaceuticals, including anticancer agents. There is no shortage of molecules; the challenge has been and continues to be methods of identifying molecules that have the potential to be therapeutically important in human malignant disease. 'Screening' remains the most important and most controversial method in cancer drug discovery. In vitro screens have generally focused on cytotoxicity and have identified several highly cytotoxic molecules. Other endpoints available in vitro are inhibition of proliferation, 3 inhibition of [ H]thymidine incorporation into DNA and various viability assays, based most frequently on dye exclusion or metabolism. Seller Inventory # 9781617370465
Buy New
£ 192.07
Convert currency
Stock Image
Cancer Therapeutics: Experimental and Clinical Agents
Published by
Humana Press
(2010)
ISBN 10: 1617370460
ISBN 13: 9781617370465
New
Paperback
Quantity: 2
Seller:
Rating
Book Description Paperback. Condition: Brand New. 464 pages. 10.00x7.01x1.05 inches. In Stock. Seller Inventory # x-1617370460
Buy New
£ 225.54
Convert currency